Skip to main content
. 2022 Jun 9;2022:7060466. doi: 10.1155/2022/7060466

Table 2.

Comorbidities of patients receiving TCZ.

Survived (n = 116) Deceased (n = 9) P value Improved (n = 109) Not improved (n = 16) P value

Hypertension 41 6 0.79 38 9 0.165
Diabetes 48 7 0.42 46 9 0.419
Dyslipidemia 23 3 0.392 22 4 0.742
Pulmonary disease 9 1 0.54 8 2 0.615
Obesity 57 4 0.791 54 7 1.00
Cardiovascular disease 6 4 0.002 5 5 0.003
Renal insufficiency 1 2 0.013 0 3 0.002
Smoking 10 0 1.00 9 1 1.00
Others 26 6 0.009 23 9 0.005